Evidence map›Paper›PMID 33598154›Full record

ArticleFood science & nutrition2021

Probiotic

Babak Pakbin, Shaghayegh Pishkhan Dibazar, Samaneh Allahyari, Maryam Javadi, Alireza Farasat, Sina Darzi

Open access · hybridAbstract read
In one paragraph

Article in Food science & nutrition, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 28 citations in OpenAlex.

  1. Microbiota in cancer: current understandings and future perspectives.Signal transduction and targeted therapy · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Effects of ProbioticInternational journal of molecular sciences · 2023
    Article
  9. Article
  10. Review
  11. Review
  12. Probiotic YeastJournal of fungi (Basel, Switzerland) · 2022
    Review
  13. Review
  14. ProbioticFood science & nutrition · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Babak PakbinDepartment of Food Hygiene and Quality of Control Faculty of Veterinary Medicine University of Tehran Tehran Iran.ORCID https://orcid.org/0000-0003-1412-0890
Shaghayegh Pishkhan DibazarDepartment of Immunology Faculty of Medical Science Tarbiat Modares University Tehran Iran.
Samaneh AllahyariDepartment of Food Hygiene and Safety School of Health Qazvin University of Medical sciences Qazvin Iran.
Maryam JavadiChildren Growth and Development Research Center Research Institute for prevention of Non- Communicable Disease Qazvin University of Medical Sciences Qazvin Iran.ORCID https://orcid.org/0000-0002-7185-8472
Alireza FarasatCellular and Molecular Research Center Research Institute for prevention of Non-Communicable Disease Qazvin University of Medical Sciences Qazvin Iran.
Sina DarziHealth Products Safety Research Center Qazvin University of Medical Science Qazvin Iran.
Qazvin University of Medical Sciences · IRTarbiat Modares University · IRUniversity of Tehran · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Natural anticancer drug and compounds with other great benefits are of interest recently due to lower side effects than chemotherapy for cancer treatment and prevention. Different natural and synthetic drugs have been suggested to be used for treatment of gastric cancers, the second deadly cancer worldwide. The aim of this study was to investigate anticancer activity of SBS including inducing apoptosis and inhibition of survivin gene expression in gastric cancer cells. We evaluated cell viability, inducing apoptosis and change in survivin gene expression of EPG85-257P (EPG) and EPG85-257RDB (resistant to Daunorubicin, RDB) cell lines under exposure of SBS after 24, 48, and 72 hr. We found that SBS decreased cell viability, induced apoptosis, and reduced survivin gene expression in treated EPG and RDB cells (with the significant IC

Indexed as

apoptosisgastric cancer cellsSaccharomyces boulardii supernatantsurvivin gene expression

Identifiers

PMID33598154
PMCPMC7866606
OpenAlexW3110420689

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.